The European Venus Explorer (EVE) mission was proposed to the European Space Agency in 2007, as an M-class mission under the Cosmic Vision Programme. Although it has not been chosen in the 2007 selection round for programmatic reasons, the EVE mission may serve as a useful reference point for future missions, so it is described here. It consists of one balloon platform floating at an altitude of 50-60 km, one descent probe provided by Russia, and an orbiter with a polar orbit which will relay data from the balloon and descent probe, and perform science observations. The balloon type preferred for scientific goals is one which oscillates in altitude through the cloud deck. To achieve this flight profile, the balloon envelope contains a phase change fluid, which results in a flight profile which oscillates in height. The nominal balloon lifetime is 7 days-enough for one full circumnavigation of the planet. The descent probe's fall through the atmosphere takes 60 min, followed by 30 min of operation on the surface. The key measurement objectives of EVE are: (1) in situ measurement from the balloon of noble gas abundances and stable isotope ratios, to study the record of the evolution of Venus; (2) in situ balloon-borne measurement of cloud particle and gas composition, and their spatial variation, to understand the complex cloud-level chemistry; (3) in situ measurements of environmental parameters and winds (from tracking of the balloon) for one rotation around the planet, to understand atmospheric dynamics and radiative balance in this crucial region. The portfolio of key measurements is complemented by the Russian descent probe, which enables the investigation of the deep atmosphere and surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.